Newsbenzinga
Reported Sunday, CEL-SCI Prices Best-Efforts Offering Of 2.5M Shares At $1.00 Per Share To Raise $2.5M For Continued Development Of Multikine Cancer Immunotherapy
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…